Lolkje TW De Jong - van den Berg
Affiliation: University of Groningen
Country: The Netherlands
- HRT use in 2001 and 2004 in The Netherlands--a world of differenceLolkje T W de Jong-van den Berg
Groningen University Institute for Drug Exploration GUIDE, University of Groningen, Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
Maturitas 54:193-7. 2006..Therefore, we compare the prescribing of HRT in 2004 (after) with that of 2001 (before the publications) in The Netherlands...
- Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?H Dolk
Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute for Drug Exploration GUIDE, University of Groningen, The Netherlands, Ant Deusinglaan 1, 9713 AV Groningen The Netherlands
Neurology 71:714-22. 2008....
- Patient-reporting of side effects may provide an important source of information in clinical practiceJuliet M Foster
Eur J Clin Pharmacol 63:979-80; author reply 981. 2007
- Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trialJanna M Munster
University of Groningen, University Centre for Pharmacy, Pharmacoepidemiology and Pharmacoeconomics, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
BMC Womens Health 10:32. 2010..We designed a trial to assess the (cost-)effectiveness of a screening program for Q fever in pregnant women living in risks areas in The Netherlands...